Form 4: NEPH CFO Exercises Options, Boosts Stake
Insider Transaction Report
Nephros Inc.'s Chief Financial Officer, Judy Krandel, exercised options to acquire 68,861 shares of common stock at $1.71 per share.
Summary
- Judy Krandel, Chief Financial Officer of Nephros Inc. (NEPH), acquired 68,861 shares of common stock through the exercise of stock options on March 23, 2026.
- The exercise price for these shares was $1.71 per share.
- Following this transaction, Krandel directly beneficially owns 68,861 shares of common stock.
- Krandel still holds derivative securities in the form of stock options:
- An option to buy 53,663 shares at $1.71, with vesting scheduled for 30,631 shares on November 1, 2024, and the remaining 91,893 shares vesting quarterly in 12 equal amounts commencing February 1, 2025.
- An option to buy 54,359 shares at $1.68, with vesting scheduled for 13,589 shares on March 27, 2026, and the remaining 40,770 shares vesting quarterly in 12 equal amounts commencing June 27, 2026.
- An option to buy 4,000 shares at $2.92, with vesting scheduled for 1,000 shares on March 16, 2027, and the remaining 3,000 shares vesting quarterly in 12 equal amounts commencing June 16, 2027.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a moderately positive signal. The exercise of options by a key executive, increasing their direct stake, generally indicates confidence in the company's future performance, although it is a routine compensation-related event.
Positives
- The Chief Financial Officer's exercise of stock options and subsequent increase in direct beneficial ownership can signal confidence in the company's future prospects.
- The transaction aligns management's financial interests more closely with those of shareholders.
Future Outlook
This Form 4 filing does not contain forward-looking statements or guidance, as it is a disclosure of a past insider transaction.
Industry Context
StockSavvy.ai notes that insider transactions, such as the exercise of stock options by a Chief Financial Officer, are often monitored by investors as they can provide insights into management's perception of the company's value and future prospects. An increase in direct ownership typically aligns management's interests with those of shareholders, which is generally viewed positively.
Related Party Transactions
- The transaction involves an insider (Chief Financial Officer) acquiring company stock, which is a common form of related party dealing in the context of executive compensation.
Stakeholder Impact
- Shareholders: Increased alignment of interests between the CFO and shareholders, potentially signaling management's belief in the company's value.
- Employees: No direct impact on general employees is indicated by this filing.
Next Steps
- Future vesting of remaining stock options held by Judy Krandel on various dates through 2027.
Key Dates
| Date | Description |
|---|---|
| 11/01/2024 | Vesting date for 30,631 shares of stock options with an exercise price of $1.71. |
| 02/01/2025 | Commencement of quarterly vesting for 91,893 shares of stock options (in 12 equal amounts) with an exercise price of $1.71. |
| 03/23/2026 | Date of stock option exercise by Judy Krandel, acquiring 68,861 shares of common stock. |
| 03/25/2026 | Signature date of the Form 4 filing. |
| 03/27/2026 | Vesting date for 13,589 shares of stock options with an exercise price of $1.68. |
| 06/27/2026 | Commencement of quarterly vesting for 40,770 shares of stock options (in 12 equal amounts) with an exercise price of $1.68. |
| 03/16/2027 | Vesting date for 1,000 shares of stock options with an exercise price of $2.92. |
| 06/16/2027 | Commencement of quarterly vesting for 3,000 shares of stock options (in 12 equal amounts) with an exercise price of $2.92. |
| 11/01/2033 | Expiration date for stock options with an exercise price of $1.71. |
| 03/27/2035 | Expiration date for stock options with an exercise price of $1.68. |
| 03/16/2036 | Expiration date for stock options with an exercise price of $2.92. |
Keywords
Nephros Inc, NEPH, Judy Krandel, CFO, Stock Option Exercise, Insider Transaction, Beneficial Ownership, SEC Form 4
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.